The Drug Enforcement Administration published a final rule listing the synthetic cathinone 3,4-methylenedioxy-N-methylcathinone, or methylone, in Schedule I (78 Fed. Reg. 21818).  The substance is one of several “designer drugs” that DEA has been in the processing of scheduling. In October 2011, DEA used the imminent hazard provisions of the Controlled Substances Act to place meth... Read More